Sermorelin 10mg

Sermorelin | GHRH Signaling Research Compound

Sermorelin is a synthetic analog of Growth Hormone-Releasing Hormone (GHRH) studied for its interaction with GHRH receptors and associated pituitary signaling pathways. It provides a laboratory research model for investigating endogenous growth hormone regulation and related neuroendocrine mechanisms.

Key Research Areas:

• GHRH Receptor Signaling — Sermorelin is studied for its interaction with GHRH receptors and associated downstream molecular signaling pathways.
• Pituitary Signaling Research — Laboratory models examine Sermorelin in relation to pituitary cellular activity and endogenous growth hormone signaling.
• Growth Hormone Regulation Research — Experimental studies investigate the mechanisms involved in GHRH-mediated growth hormone release and regulation.
• GH/IGF-1 Axis Research — Sermorelin is studied in relation to growth hormone signaling and downstream IGF-1-associated pathways.
• Comparative GHRH Research — Sermorelin provides a research model for comparing GHRH-related compounds and their molecular signaling characteristics.

Product Specifications:

• Synthetic GHRH analog research compound
• Supplied as lyophilized powder
• Batch-specific purity and identity information available via applicable COA
• Store according to applicable laboratory storage requirements; protect from light and moisture

For laboratory and research use only. Not intended for human or animal consumption, administration, diagnostic, or therapeutic use. Not a drug, dietary supplement, or cosmetic.